Global Diabetes Drug Therapy Market Insights and Forecast to 2028

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.

Market Analysis and Insights: Global Diabetes Drug Therapy Market

The global Diabetes Drug Therapy market size is projected to reach US$ 19490 million by 2028, from US$ 9700 million in 2021, at a CAGR of 10.0% during 2022-2028.

Fully considering the economic change by this health crisis, Oral accounting for % of the Diabetes Drug Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Online Pharmacies segment is altered to an % CAGR throughout this forecast period.

China Diabetes Drug Therapy market size is valued at US$ million in 2021, while the North America and Europe Diabetes Drug Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Diabetes Drug Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Drug Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Drug Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Drug Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Drug Therapy market.

Global Diabetes Drug Therapy Scope and Market Size

Diabetes Drug Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Diabetes Drug Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Oral

Subcutaneous

Intravenous

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Abbott Laboratories

Mannkind Corporation

Bristol Myers Squibb

Medtronic

AstraZeneca

Eli Lilly and Company

GlaxoSmithKline

Sanofi

Novo Nordisk

Novartis International AG

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Oral

1.2.3 Subcutaneous

1.2.4 Intravenous

1.3 Market by Application

1.3.1 Global Diabetes Drug Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Online Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Retail Pharmacies

1.4 Study Objectives

1.5 Years Considered

2.1 Global Diabetes Drug Therapy Market Perspective (2017-2028)

2.2 Diabetes Drug Therapy Growth Trends by Region

2.2.1 Diabetes Drug Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Diabetes Drug Therapy Historic Market Size by Region (2017-2022)

2.2.3 Diabetes Drug Therapy Forecasted Market Size by Region (2023-2028)

2.3 Diabetes Drug Therapy Market Dynamics

2.3.1 Diabetes Drug Therapy Industry Trends

2.3.2 Diabetes Drug Therapy Market Drivers

2.3.3 Diabetes Drug Therapy Market Challenges

2.3.4 Diabetes Drug Therapy Market Restraints

3.1 Global Top Diabetes Drug Therapy Players by Revenue

3.1.1 Global Top Diabetes Drug Therapy Players by Revenue (2017-2022)

3.1.2 Global Diabetes Drug Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetes Drug Therapy Revenue

3.4 Global Diabetes Drug Therapy Market Concentration Ratio

3.4.1 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetes Drug Therapy Revenue in 2021

3.5 Diabetes Drug Therapy Key Players Head office and Area Served

3.6 Key Players Diabetes Drug Therapy Product Solution and Service

3.7 Date of Enter into Diabetes Drug Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Diabetes Drug Therapy Historic Market Size by Type (2017-2022)

4.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2023-2028)

5.1 Global Diabetes Drug Therapy Historic Market Size by Application (2017-2022)

5.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2023-2028)

6.1 North America Diabetes Drug Therapy Market Size (2017-2028)

6.2 North America Diabetes Drug Therapy Market Size by Type

6.2.1 North America Diabetes Drug Therapy Market Size by Type (2017-2022)

6.2.2 North America Diabetes Drug Therapy Market Size by Type (2023-2028)

6.2.3 North America Diabetes Drug Therapy Market Share by Type (2017-2028)

6.3 North America Diabetes Drug Therapy Market Size by Application

6.3.1 North America Diabetes Drug Therapy Market Size by Application (2017-2022)

6.3.2 North America Diabetes Drug Therapy Market Size by Application (2023-2028)

6.3.3 North America Diabetes Drug Therapy Market Share by Application (2017-2028)

6.4 North America Diabetes Drug Therapy Market Size by Country

6.4.1 North America Diabetes Drug Therapy Market Size by Country (2017-2022)

6.4.2 North America Diabetes Drug Therapy Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Diabetes Drug Therapy Market Size (2017-2028)

7.2 Europe Diabetes Drug Therapy Market Size by Type

7.2.1 Europe Diabetes Drug Therapy Market Size by Type (2017-2022)

7.2.2 Europe Diabetes Drug Therapy Market Size by Type (2023-2028)

7.2.3 Europe Diabetes Drug Therapy Market Share by Type (2017-2028)

7.3 Europe Diabetes Drug Therapy Market Size by Application

7.3.1 Europe Diabetes Drug Therapy Market Size by Application (2017-2022)

7.3.2 Europe Diabetes Drug Therapy Market Size by Application (2023-2028)

7.3.3 Europe Diabetes Drug Therapy Market Share by Application (2017-2028)

7.4 Europe Diabetes Drug Therapy Market Size by Country

7.4.1 Europe Diabetes Drug Therapy Market Size by Country (2017-2022)

7.4.2 Europe Diabetes Drug Therapy Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Diabetes Drug Therapy Market Size (2017-2028)

8.2 Asia-Pacific Diabetes Drug Therapy Market Size by Type

8.2.1 Asia-Pacific Diabetes Drug Therapy Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Diabetes Drug Therapy Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Diabetes Drug Therapy Market Share by Type (2017-2028)

8.3 Asia-Pacific Diabetes Drug Therapy Market Size by Application

8.3.1 Asia-Pacific Diabetes Drug Therapy Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Diabetes Drug Therapy Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Diabetes Drug Therapy Market Share by Application (2017-2028)

8.4 Asia-Pacific Diabetes Drug Therapy Market Size by Region

8.4.1 Asia-Pacific Diabetes Drug Therapy Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Diabetes Drug Therapy Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Diabetes Drug Therapy Market Size (2017-2028)

9.2 Latin America Diabetes Drug Therapy Market Size by Type

9.2.1 Latin America Diabetes Drug Therapy Market Size by Type (2017-2022)

9.2.2 Latin America Diabetes Drug Therapy Market Size by Type (2023-2028)

9.2.3 Latin America Diabetes Drug Therapy Market Share by Type (2017-2028)

9.3 Latin America Diabetes Drug Therapy Market Size by Application

9.3.1 Latin America Diabetes Drug Therapy Market Size by Application (2017-2022)

9.3.2 Latin America Diabetes Drug Therapy Market Size by Application (2023-2028)

9.3.3 Latin America Diabetes Drug Therapy Market Share by Application (2017-2028)

9.4 Latin America Diabetes Drug Therapy Market Size by Country

9.4.1 Latin America Diabetes Drug Therapy Market Size by Country (2017-2022)

9.4.2 Latin America Diabetes Drug Therapy Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Diabetes Drug Therapy Market Size (2017-2028)

10.2 Middle East & Africa Diabetes Drug Therapy Market Size by Type

10.2.1 Middle East & Africa Diabetes Drug Therapy Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Diabetes Drug Therapy Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Diabetes Drug Therapy Market Share by Type (2017-2028)

10.3 Middle East & Africa Diabetes Drug Therapy Market Size by Application

10.3.1 Middle East & Africa Diabetes Drug Therapy Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Diabetes Drug Therapy Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Diabetes Drug Therapy Market Share by Application (2017-2028)

10.4 Middle East & Africa Diabetes Drug Therapy Market Size by Country

10.4.1 Middle East & Africa Diabetes Drug Therapy Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Diabetes Drug Therapy Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Diabetes Drug Therapy Introduction

11.1.4 Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2017-2022)

11.1.5 Abbott Laboratories Recent Developments

11.2 Mannkind Corporation

11.2.1 Mannkind Corporation Company Details

11.2.2 Mannkind Corporation Business Overview

11.2.3 Mannkind Corporation Diabetes Drug Therapy Introduction

11.2.4 Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2017-2022)

11.2.5 Mannkind Corporation Recent Developments

11.3 Bristol Myers Squibb

11.3.1 Bristol Myers Squibb Company Details

11.3.2 Bristol Myers Squibb Business Overview

11.3.3 Bristol Myers Squibb Diabetes Drug Therapy Introduction

11.3.4 Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2017-2022)

11.3.5 Bristol Myers Squibb Recent Developments

11.4 Medtronic

11.4.1 Medtronic Company Details

11.4.2 Medtronic Business Overview

11.4.3 Medtronic Diabetes Drug Therapy Introduction

11.4.4 Medtronic Revenue in Diabetes Drug Therapy Business (2017-2022)

11.4.5 Medtronic Recent Developments

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Diabetes Drug Therapy Introduction

11.5.4 AstraZeneca Revenue in Diabetes Drug Therapy Business (2017-2022)

11.5.5 AstraZeneca Recent Developments

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Details

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company Diabetes Drug Therapy Introduction

11.6.4 Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2017-2022)

11.6.5 Eli Lilly and Company Recent Developments

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Diabetes Drug Therapy Introduction

11.7.4 GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2017-2022)

11.7.5 GlaxoSmithKline Recent Developments

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Diabetes Drug Therapy Introduction

11.8.4 Sanofi Revenue in Diabetes Drug Therapy Business (2017-2022)

11.8.5 Sanofi Recent Developments

11.9 Novo Nordisk

11.9.1 Novo Nordisk Company Details

11.9.2 Novo Nordisk Business Overview

11.9.3 Novo Nordisk Diabetes Drug Therapy Introduction

11.9.4 Novo Nordisk Revenue in Diabetes Drug Therapy Business (2017-2022)

11.9.5 Novo Nordisk Recent Developments

11.10 Novartis International AG

11.10.1 Novartis International AG Company Details

11.10.2 Novartis International AG Business Overview

11.10.3 Novartis International AG Diabetes Drug Therapy Introduction

11.10.4 Novartis International AG Revenue in Diabetes Drug Therapy Business (2017-2022)

11.10.5 Novartis International AG Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Diabetes Drug Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Oral

    Table 3. Key Players of Subcutaneous

    Table 4. Key Players of Intravenous

    Table 5. Global Diabetes Drug Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Diabetes Drug Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Diabetes Drug Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Diabetes Drug Therapy Market Share by Region (2017-2022)

    Table 9. Global Diabetes Drug Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Diabetes Drug Therapy Market Share by Region (2023-2028)

    Table 11. Diabetes Drug Therapy Market Trends

    Table 12. Diabetes Drug Therapy Market Drivers

    Table 13. Diabetes Drug Therapy Market Challenges

    Table 14. Diabetes Drug Therapy Market Restraints

    Table 15. Global Diabetes Drug Therapy Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Diabetes Drug Therapy Revenue Share by Players (2017-2022)

    Table 17. Global Top Diabetes Drug Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Drug Therapy as of 2021)

    Table 18. Ranking of Global Top Diabetes Drug Therapy Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Diabetes Drug Therapy Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Diabetes Drug Therapy Product Solution and Service

    Table 22. Date of Enter into Diabetes Drug Therapy Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Diabetes Drug Therapy Revenue Market Share by Type (2017-2022)

    Table 26. Global Diabetes Drug Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Diabetes Drug Therapy Revenue Market Share by Type (2023-2028)

    Table 28. Global Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Diabetes Drug Therapy Revenue Share by Application (2017-2022)

    Table 30. Global Diabetes Drug Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Diabetes Drug Therapy Revenue Share by Application (2023-2028)

    Table 32. North America Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 33. North America Diabetes Drug Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 34. North America Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 35. North America Diabetes Drug Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 36. North America Diabetes Drug Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 37. North America Diabetes Drug Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 38. Europe Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 39. Europe Diabetes Drug Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 40. Europe Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 41. Europe Diabetes Drug Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 42. Europe Diabetes Drug Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 43. Europe Diabetes Drug Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Diabetes Drug Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 46. Asia Pacific Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 47. Asia Pacific Diabetes Drug Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 48. Asia Pacific Diabetes Drug Therapy Market Size by Region (2017-2022) & (US$ Million)

    Table 49. Asia Pacific Diabetes Drug Therapy Market Size by Region (2023-2028) & (US$ Million)

    Table 50. Latin America Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 51. Latin America Diabetes Drug Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 52. Latin America Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 53. Latin America Diabetes Drug Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 54. Latin America Diabetes Drug Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 55. Latin America Diabetes Drug Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Diabetes Drug Therapy Market Size by Type (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Diabetes Drug Therapy Market Size by Type (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Diabetes Drug Therapy Market Size by Application (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Diabetes Drug Therapy Market Size by Application (2023-2028) & (US$ Million)

    Table 60. Middle East and Africa Diabetes Drug Therapy Market Size by Country (2017-2022) & (US$ Million)

    Table 61. Middle East and Africa Diabetes Drug Therapy Market Size by Country (2023-2028) & (US$ Million)

    Table 62. Abbott Laboratories Company Details

    Table 63. Abbott Laboratories Business Overview

    Table 64. Abbott Laboratories Diabetes Drug Therapy Product

    Table 65. Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 66. Abbott Laboratories Recent Developments

    Table 67. Mannkind Corporation Company Details

    Table 68. Mannkind Corporation Business Overview

    Table 69. Mannkind Corporation Diabetes Drug Therapy Product

    Table 70. Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 71. Mannkind Corporation Recent Developments

    Table 72. Bristol Myers Squibb Company Details

    Table 73. Bristol Myers Squibb Business Overview

    Table 74. Bristol Myers Squibb Diabetes Drug Therapy Product

    Table 75. Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 76. Bristol Myers Squibb Recent Developments

    Table 77. Medtronic Company Details

    Table 78. Medtronic Business Overview

    Table 79. Medtronic Diabetes Drug Therapy Product

    Table 80. Medtronic Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 81. Medtronic Recent Developments

    Table 82. AstraZeneca Company Details

    Table 83. AstraZeneca Business Overview

    Table 84. AstraZeneca Diabetes Drug Therapy Product

    Table 85. AstraZeneca Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 86. AstraZeneca Recent Developments

    Table 87. Eli Lilly and Company Company Details

    Table 88. Eli Lilly and Company Business Overview

    Table 89. Eli Lilly and Company Diabetes Drug Therapy Product

    Table 90. Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 91. Eli Lilly and Company Recent Developments

    Table 92. GlaxoSmithKline Company Details

    Table 93. GlaxoSmithKline Business Overview

    Table 94. GlaxoSmithKline Diabetes Drug Therapy Product

    Table 95. GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 96. GlaxoSmithKline Recent Developments

    Table 97. Sanofi Company Details

    Table 98. Sanofi Business Overview

    Table 99. Sanofi Diabetes Drug Therapy Product

    Table 100. Sanofi Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 101. Sanofi Recent Developments

    Table 102. Novo Nordisk Company Details

    Table 103. Novo Nordisk Business Overview

    Table 104. Novo Nordisk Diabetes Drug Therapy Product

    Table 105. Novo Nordisk Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 106. Novo Nordisk Recent Developments

    Table 107. Novartis International AG Company Details

    Table 108. Novartis International AG Business Overview

    Table 109. Novartis International AG Diabetes Drug Therapy Product

    Table 110. Novartis International AG Revenue in Diabetes Drug Therapy Business (2017-2022) & (US$ Million)

    Table 111. Novartis International AG Recent Developments

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Diabetes Drug Therapy Market Share by Type: 2021 VS 2028

    Figure 2. Oral Features

    Figure 3. Subcutaneous Features

    Figure 4. Intravenous Features

    Figure 5. Global Diabetes Drug Therapy Market Share by Application: 2021 VS 2028

    Figure 6. Online Pharmacies Case Studies

    Figure 7. Hospital Pharmacies Case Studies

    Figure 8. Retail Pharmacies Case Studies

    Figure 9. Diabetes Drug Therapy Report Years Considered

    Figure 10. Global Diabetes Drug Therapy Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Diabetes Drug Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Diabetes Drug Therapy Market Share by Region: 2021 VS 2028

    Figure 13. Global Diabetes Drug Therapy Market Share by Players in 2021

    Figure 14. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Drug Therapy as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Diabetes Drug Therapy Revenue in 2021

    Figure 16. North America Diabetes Drug Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 17. North America Diabetes Drug Therapy Market Size Market Share by Type (2017-2028)

    Figure 18. North America Diabetes Drug Therapy Market Size Market Share by Application (2017-2028)

    Figure 19. North America Diabetes Drug Therapy Market Size Share by Country (2017-2028)

    Figure 20. United States Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Canada Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 22. Europe Diabetes Drug Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 23. Europe Diabetes Drug Therapy Market Size Market Share by Type (2017-2028)

    Figure 24. Europe Diabetes Drug Therapy Market Size Market Share by Application (2017-2028)

    Figure 25. Europe Diabetes Drug Therapy Market Size Share by Country (2017-2028)

    Figure 26. Germany Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. France Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. U.K. Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Italy Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Russia Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Nordic Countries Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. Asia-Pacific Diabetes Drug Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 33. Asia Pacific Diabetes Drug Therapy Market Size Market Share by Type (2017-2028)

    Figure 34. Asia Pacific Diabetes Drug Therapy Market Size Market Share by Application (2017-2028)

    Figure 35. Asia Pacific Diabetes Drug Therapy Market Size Share by Region (2017-2028)

    Figure 36. China Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Japan Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. South Korea Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Southeast Asia Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. India Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Australia Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

    Figure 42. Latin America Diabetes Drug Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 43. Latin America Diabetes Drug Therapy Market Size Market Share by Type (2017-2028)

    Figure 44. Latin America Diabetes Drug Therapy Market Size Market Share by Application (2017-2028)

    Figure 45. Latin America Diabetes Drug Therapy Market Size Share by Country (2017-2028)

    Figure 46. Mexico Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Brazil Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 48. Middle East & Africa Diabetes Drug Therapy Market Size YoY (2017-2028) & (US$ Million)

    Figure 49. Middle East and Africa Diabetes Drug Therapy Market Size Market Share by Type (2017-2028)

    Figure 50. Middle East and Africa Diabetes Drug Therapy Market Size Market Share by Application (2017-2028)

    Figure 51. Middle East and Africa Diabetes Drug Therapy Market Size Share by Country (2017-2028)

    Figure 52. Turkey Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. Saudi Arabia Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. UAE Diabetes Drug Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 55. Abbott Laboratories Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 56. Mannkind Corporation Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 57. Bristol Myers Squibb Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 58. Medtronic Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 59. AstraZeneca Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 60. Eli Lilly and Company Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 61. GlaxoSmithKline Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 62. Sanofi Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 63. Novo Nordisk Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 64. Novartis International AG Revenue Growth Rate in Diabetes Drug Therapy Business (2017-2022)

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed